Stocks Explorer
Stocks
Sectors
Search
Viridian Therapeutics Inc.(0K1R) News
Profile
Chart
News
Analysis
0K1R price today
by TradingView
Date
Title
Jan 8
Viridian Therapeutics Highlights 2025 Corporate Priorities Following Positive Phase 3 Topline Data in Thyroid Eye Disease
‹ Prev
Page
of 1
Next ›